AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca u.S. Personal Consumption Expenditures — Health Care Services, SAAR ($B) ($M)
FRED / U.S. Bureau of Economic Analysis (DHLCRC1Q027SBEA)
Latest, Q2 2026
3,790
Period ended Jun 30, 2026
Change on a year earlier
+7.4%
3,530 in Q2 2025
History
30 quarters
Since Q1 2019
Sources
1
FRED / U.S. Bureau of Economic Analysis (DHLCRC1Q027SBEA)
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). AstraZeneca U.S. Personal Consumption Expenditures — Health Care Services, SAAR ($B) ($M), quarterly Q1 2019–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fred_pce_healthcare
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.